InvestorsHub Logo
Followers 48
Posts 2740
Boards Moderated 0
Alias Born 02/06/2017

Re: ATLnsider post# 304324

Friday, 09/04/2020 4:53:04 AM

Friday, September 04, 2020 4:53:04 AM

Post# of 689566
ATL - Thank You.

Friday, November 20, 2020

LTBK-02 - Phase III Clinical Trial to Test the Safety and Efficacy of Autologous Tumor Lysate-Loaded Dendritic Cells in Patients with Newly Diagnosed Glioblastoma

Learning Objectives:

Upon completion, participant will be able to better understand the impact of dendritic cell-based immunization strategies o the course of disease in glioblastoma patients.

Upon completion, participant will be able to assess whether patients with glioblastoma live longer if treated with dendritic cell-based immunization strategies.

https://www.eventscribe.com/2020/SNO/fsPopup.asp?efp=S0taQ1hBSFkxMTYzNQ&PresentationID=772799&rnd=0.2810788&query=Dcvax&mode=presinfo
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News